BGT-007

N/A

Report date: 2024/07/10 11:08:18
First In Class

Base Information

Drug NameBGT-007
Drug Alias NameBGT007H Cell TherapyBGT007BGT-007BGT-007HBGT007H
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsEndometrial NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou Bioresette Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Bioresette Biomedical Technology Co LtdBiosyngen Pte Ltd
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A